Announcement on Preliminary Earnings Estimate for 2024
Filed with SSE · · 3 pages · Chinese
Youcare Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Youcare Pharmaceutical
- Announcement on Voluntary Disclosure of FDA Approval for Clinical Trial of the Subsidiary's YKYY025 Injection
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
- Announcement on Description of Recent Related Matters
- Notice on Convening the 1st Extraordinary General Meeting in 2025
Later from Youcare Pharmaceutical
- Announcement on 2024 Annual Profit Distribution Plan
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Voluntary Disclosure of Ganciclovir for Injection Passing Consistency Evaluation of Quality and Efficacy of Generic Drugs
- Announcement on Reply to Inquiry Letter of 2024 Annual Report from Shanghai Stock Exchange
- Announcement on the Results of Shareholding Increase by Actual Controllers and Directors
Follow Youcare Pharmaceutical into a list and get an email when it puts out news.
Follow Youcare Pharmaceutical